Otogenetics Corporation – Trademark Portfolio
Entity Type: 03
Otogenetics Corporation holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include GXVISION, OTOGENETICS CORPORATION, ENVISION PRENATAL SCREENING, and SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST. The owner is based in Atlanta, GA.
Suite 100
4553 Winters Chapel Rd.
Atlanta, GA 30360
Showing of trademarks Trademarks
Trademark Classifications
Otogenetics Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Otogenetics Corporation have?
Otogenetics Corporation has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Otogenetics Corporation file in?
Otogenetics Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Otogenetics Corporation's most well-known trademarks?
Otogenetics Corporation's registered trademark portfolio includes well-known marks such as GXVISION, OTOGENETICS CORPORATION, ENVISION PRENATAL SCREENING, and SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST. These are among 4 currently registered trademarks in the portfolio.
What is Otogenetics Corporation's trademark registration success rate?
Otogenetics Corporation has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.